Nilsine Partners LLC Sells 652 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Nilsine Partners LLC lessened its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.6% in the first quarter, Holdings Channel reports. The firm owned 13,625 shares of the pharmacy operator’s stock after selling 652 shares during the period. Nilsine Partners LLC’s holdings in Walgreens Boots Alliance were worth $296,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Exchange Traded Concepts LLC purchased a new stake in shares of Walgreens Boots Alliance in the 3rd quarter valued at about $398,000. Czech National Bank increased its position in shares of Walgreens Boots Alliance by 47.8% during the 3rd quarter. Czech National Bank now owns 125,260 shares of the pharmacy operator’s stock valued at $2,786,000 after purchasing an additional 40,486 shares during the last quarter. Asset Management One Co. Ltd. increased its position in shares of Walgreens Boots Alliance by 1.5% during the 3rd quarter. Asset Management One Co. Ltd. now owns 515,429 shares of the pharmacy operator’s stock valued at $11,463,000 after purchasing an additional 7,470 shares during the last quarter. First Personal Financial Services bought a new position in shares of Walgreens Boots Alliance during the 3rd quarter valued at about $38,000. Finally, MCF Advisors LLC increased its position in shares of Walgreens Boots Alliance by 99.3% during the 3rd quarter. MCF Advisors LLC now owns 3,332 shares of the pharmacy operator’s stock valued at $74,000 after purchasing an additional 1,660 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.

Analysts Set New Price Targets

WBA has been the topic of a number of recent analyst reports. Leerink Partnrs reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. TheStreet upgraded Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research note on Monday, January 8th. SVB Leerink lowered their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research note on Monday, March 18th. Truist Financial reiterated a “hold” rating and set a $25.00 price objective on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. Finally, Morgan Stanley lowered their price objective on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a research note on Monday, April 1st. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $24.36.

Insider Buying and Selling

In other news, Director Inderpal S. Bhandari purchased 3,000 shares of the stock in a transaction on Thursday, April 11th. The stock was bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the transaction, the director now owns 3,000 shares in the company, valued at approximately $54,150. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, CFO Manmohan Mahajan acquired 6,000 shares of the business’s stock in a transaction on Tuesday, April 2nd. The stock was bought at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the purchase, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the business’s stock in a transaction on Thursday, April 11th. The shares were purchased at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the purchase, the director now owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is owned by company insiders.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ WBA traded down $0.29 during mid-day trading on Tuesday, reaching $17.73. The company’s stock had a trading volume of 8,249,794 shares, compared to its average volume of 13,664,933. The firm has a market capitalization of $15.30 billion, a PE ratio of -2.53, a P/E/G ratio of 1.10 and a beta of 0.73. Walgreens Boots Alliance, Inc. has a 52 week low of $17.49 and a 52 week high of $35.36. The stock has a fifty day moving average of $19.84 and a two-hundred day moving average of $21.68. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The firm had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. During the same period last year, the company earned $1.16 EPS. Walgreens Boots Alliance’s quarterly revenue was up 6.3% compared to the same quarter last year. As a group, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Monday, May 20th. This represents a $1.00 annualized dividend and a yield of 5.64%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -14.29%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.